Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipients
Objective: to analyze the correlation between the expression levels of microRNA-101, microRNA-142, microRNA-27, microRNA-339, and microRNA-424 and the plasma concentrations of biomarkers that are potentially significant for the diagnosis of post-transplant complications in heart recipients. Material...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2020-10-01
|
| Series: | Vestnik Transplantologii i Iskusstvennyh Organov |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/1229 |
| _version_ | 1797871932663660544 |
|---|---|
| author | D. A. Velikiy O. E. Gichkun A. A. Ulybysheva S. O. Sharapchenko A. V. Marchenko O. P. Shevchenko A. O. Shevchenko |
| author_facet | D. A. Velikiy O. E. Gichkun A. A. Ulybysheva S. O. Sharapchenko A. V. Marchenko O. P. Shevchenko A. O. Shevchenko |
| author_sort | D. A. Velikiy |
| collection | DOAJ |
| description | Objective: to analyze the correlation between the expression levels of microRNA-101, microRNA-142, microRNA-27, microRNA-339, and microRNA-424 and the plasma concentrations of biomarkers that are potentially significant for the diagnosis of post-transplant complications in heart recipients. Materials and methods. The study enrolled 72 heart recipients, among whom were 56 men (77.8%). The average age of recipients was 48.6 ± 10.9 (16 to 70) years. There were 38 patients with severe chronic heart failure, among whom were 29 men (76.3%). Patients’ mean age was 48.8 ± 9.9 (26 to 70) years. The control group consisted of 12 healthy individuals who did not differ significantly by sex and age. microRNA expression levels in blood plasma were measured via quantitative polymerase chain reaction. Plasma concentrations of VEGF-A, PLGF, MCP-1, and sCD40L were determined using a multiplex method. ST2 and Galectin-3 concentrations were measured via enzyme-linked immunosorbent assay. Results. Patients with end-stage chronic heart failure were found to have significantly higher expression levels of microRNA-27, microRNA-339 and microRNA-424 in blood plasma compared with the healthy individuals. In potential heart recipients, the expression le vels of microRNA-339 and microRNA-424 correlated with serum galectin-3 concentrations, microRNA-101 expression levels correlated with PLGF-1 concentrations, while microRNA-27 expression levels correlated with plasma MCP-1 concentrations. In the early post-transplant period, the expression levels of microRNA-101, microRNA-339, and microRNA-424 in heart recipients were significantly lower than in patients with severe chronic heart failure. In the early post-transplant period (one year or more after transplantation), microRNA-101 and microRNA-27 expression levels were significantly higher than in heart recipients. A year or more after transplantation, the following correlations were found in heart recipients: microRNA-142 expression level correlated with serum levels of galectin-3 (p = 0.05), microRNA-27 and microRNA-424 expression levels correlated with ST2 concentrations (p = 0.02), microRNA-27 expression level correlated with PLGF-1 concentrations (p = 0.02), while microRNA-101 expression level correlated with serum levels of PAPP-A (p = 0.05). Conclusion. In heart recipients, the expression levels of microRNA-142, microRNA-27, microRNA-424, and microRNA-101 correlate with the concentration levels of biomarkers of fibrosis (Galectin-3), rejection (ST2), neoangiogenesis (PLGF), and tissue destruction (PAPP-A). A comprehensive analysis of pre- and post-translational markers may open up new perspectives in diagnosis, assessment of the risks of post-transplant complications, and in understanding the processes leading to their development. |
| first_indexed | 2024-04-10T00:51:57Z |
| format | Article |
| id | doaj.art-6d7e4423265349bea2a56884a7fa09f1 |
| institution | Directory Open Access Journal |
| issn | 1995-1191 |
| language | Russian |
| last_indexed | 2024-04-10T00:51:57Z |
| publishDate | 2020-10-01 |
| publisher | Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov |
| record_format | Article |
| series | Vestnik Transplantologii i Iskusstvennyh Organov |
| spelling | doaj.art-6d7e4423265349bea2a56884a7fa09f12023-03-13T10:37:26ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovVestnik Transplantologii i Iskusstvennyh Organov1995-11912020-10-01223697810.15825/1995-1191-2020-3-69-78897Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipientsD. A. Velikiy0O. E. Gichkun1A. A. Ulybysheva2S. O. Sharapchenko3A. V. Marchenko4O. P. Shevchenko5A. O. Shevchenko6Shumakov National Medical Research Center of Transplantology and Artificial OrgansShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov UniversityShumakov National Medical Research Center of Transplantology and Artificial Organs; Pirogov Medical UniversityShumakov National Medical Research Center of Transplantology and Artificial OrgansShumakov National Medical Research Center of Transplantology and Artificial OrgansShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov UniversityShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University; Pirogov Medical UniversityObjective: to analyze the correlation between the expression levels of microRNA-101, microRNA-142, microRNA-27, microRNA-339, and microRNA-424 and the plasma concentrations of biomarkers that are potentially significant for the diagnosis of post-transplant complications in heart recipients. Materials and methods. The study enrolled 72 heart recipients, among whom were 56 men (77.8%). The average age of recipients was 48.6 ± 10.9 (16 to 70) years. There were 38 patients with severe chronic heart failure, among whom were 29 men (76.3%). Patients’ mean age was 48.8 ± 9.9 (26 to 70) years. The control group consisted of 12 healthy individuals who did not differ significantly by sex and age. microRNA expression levels in blood plasma were measured via quantitative polymerase chain reaction. Plasma concentrations of VEGF-A, PLGF, MCP-1, and sCD40L were determined using a multiplex method. ST2 and Galectin-3 concentrations were measured via enzyme-linked immunosorbent assay. Results. Patients with end-stage chronic heart failure were found to have significantly higher expression levels of microRNA-27, microRNA-339 and microRNA-424 in blood plasma compared with the healthy individuals. In potential heart recipients, the expression le vels of microRNA-339 and microRNA-424 correlated with serum galectin-3 concentrations, microRNA-101 expression levels correlated with PLGF-1 concentrations, while microRNA-27 expression levels correlated with plasma MCP-1 concentrations. In the early post-transplant period, the expression levels of microRNA-101, microRNA-339, and microRNA-424 in heart recipients were significantly lower than in patients with severe chronic heart failure. In the early post-transplant period (one year or more after transplantation), microRNA-101 and microRNA-27 expression levels were significantly higher than in heart recipients. A year or more after transplantation, the following correlations were found in heart recipients: microRNA-142 expression level correlated with serum levels of galectin-3 (p = 0.05), microRNA-27 and microRNA-424 expression levels correlated with ST2 concentrations (p = 0.02), microRNA-27 expression level correlated with PLGF-1 concentrations (p = 0.02), while microRNA-101 expression level correlated with serum levels of PAPP-A (p = 0.05). Conclusion. In heart recipients, the expression levels of microRNA-142, microRNA-27, microRNA-424, and microRNA-101 correlate with the concentration levels of biomarkers of fibrosis (Galectin-3), rejection (ST2), neoangiogenesis (PLGF), and tissue destruction (PAPP-A). A comprehensive analysis of pre- and post-translational markers may open up new perspectives in diagnosis, assessment of the risks of post-transplant complications, and in understanding the processes leading to their development.https://journal.transpl.ru/vtio/article/view/1229heart transplantationrejectionmicrornast2galectin-3placental growth factor (plgf)pregnancy-associated plasma protein a (papp-a) |
| spellingShingle | D. A. Velikiy O. E. Gichkun A. A. Ulybysheva S. O. Sharapchenko A. V. Marchenko O. P. Shevchenko A. O. Shevchenko Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipients Vestnik Transplantologii i Iskusstvennyh Organov heart transplantation rejection microrna st2 galectin-3 placental growth factor (plgf) pregnancy-associated plasma protein a (papp-a) |
| title | Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipients |
| title_full | Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipients |
| title_fullStr | Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipients |
| title_full_unstemmed | Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipients |
| title_short | Correlation between microRNA expression levels and plasma concentrations of biomarkers of post-transplant complications in heart transplant recipients |
| title_sort | correlation between microrna expression levels and plasma concentrations of biomarkers of post transplant complications in heart transplant recipients |
| topic | heart transplantation rejection microrna st2 galectin-3 placental growth factor (plgf) pregnancy-associated plasma protein a (papp-a) |
| url | https://journal.transpl.ru/vtio/article/view/1229 |
| work_keys_str_mv | AT davelikiy correlationbetweenmicrornaexpressionlevelsandplasmaconcentrationsofbiomarkersofposttransplantcomplicationsinhearttransplantrecipients AT oegichkun correlationbetweenmicrornaexpressionlevelsandplasmaconcentrationsofbiomarkersofposttransplantcomplicationsinhearttransplantrecipients AT aaulybysheva correlationbetweenmicrornaexpressionlevelsandplasmaconcentrationsofbiomarkersofposttransplantcomplicationsinhearttransplantrecipients AT sosharapchenko correlationbetweenmicrornaexpressionlevelsandplasmaconcentrationsofbiomarkersofposttransplantcomplicationsinhearttransplantrecipients AT avmarchenko correlationbetweenmicrornaexpressionlevelsandplasmaconcentrationsofbiomarkersofposttransplantcomplicationsinhearttransplantrecipients AT opshevchenko correlationbetweenmicrornaexpressionlevelsandplasmaconcentrationsofbiomarkersofposttransplantcomplicationsinhearttransplantrecipients AT aoshevchenko correlationbetweenmicrornaexpressionlevelsandplasmaconcentrationsofbiomarkersofposttransplantcomplicationsinhearttransplantrecipients |